191 related articles for article (PubMed ID: 37872932)
21. New perspectives on the treatment of hidradenitis suppurativa.
Amat-Samaranch V; Agut-Busquet E; Vilarrasa E; Puig L
Ther Adv Chronic Dis; 2021; 12():20406223211055920. PubMed ID: 34840709
[TBL] [Abstract][Full Text] [Related]
22. Hidradenitis suppurativa managed with adalimumab.
Yamauchi PS; Mau N
J Drugs Dermatol; 2009 Feb; 8(2):181-3. PubMed ID: 19213236
[TBL] [Abstract][Full Text] [Related]
23. Natural history, presentation, and diagnosis of hidradenitis suppurativa.
Micheletti RG
Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S51-3. PubMed ID: 25188458
[TBL] [Abstract][Full Text] [Related]
24. Rethinking Hidradenitis Suppurativa Management: Insights into Bacterial Interactions and Treatment Evolution.
Huynh FD; Damiani G; Bunick CG
Antibiotics (Basel); 2024 Mar; 13(3):. PubMed ID: 38534703
[TBL] [Abstract][Full Text] [Related]
25. [What's new in the treatment of suppurative hidradenitis in 2018 ?].
Giet G; Lebas E; Libon F; Dezfoulian B; Nikkels AF
Rev Med Liege; 2018 Sep; 73(9):468-473. PubMed ID: 30188033
[TBL] [Abstract][Full Text] [Related]
26. Itch in Hidradenitis Suppurativa/Acne Inversa: A Systematic Review.
Agarwal P; Lunge SB; Shetty NS; Karagaiah P; Daveluy S; Ortega-Loayza AG; Tzellos T; Szepietowski JC; Zouboulis CC; Grabbe S; Goldust M
J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807098
[TBL] [Abstract][Full Text] [Related]
27. Hidradenitis Suppurativa in Patients With Inflammatory Bowel Disease: A Population-Based Cohort Study in Olmsted County, Minnesota.
Yadav S; Singh S; Edakkanambeth Varayil J; Harmsen WS; Zinsmeister AR; Tremaine WJ; Davis MD; Wetter DA; Colombel JF; Loftus EV
Clin Gastroenterol Hepatol; 2016 Jan; 14(1):65-70. PubMed ID: 25952308
[TBL] [Abstract][Full Text] [Related]
28. Are dissecting cellulitis and hidradenitis suppurativa different diseases?
Federico A; Rossi A; Caro G; Magri F; Muscianese M; Di Fraia M; Carlesimo M
Clin Dermatol; 2021; 39(3):496-499. PubMed ID: 34518010
[TBL] [Abstract][Full Text] [Related]
29. Real-world safety and effectiveness of adalimumab in patients with hidradenitis suppurativa: 12-week interim analysis of post-marketing surveillance in Japan.
Hayashi N; Hayama K; Takahashi K; Kurokawa I; Okazaki M; Kashiwagi T; Iwashita E; Terui T
J Dermatol; 2022 Apr; 49(4):411-421. PubMed ID: 35040156
[TBL] [Abstract][Full Text] [Related]
30. Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.
Fotiadou C; Vakirlis E; Ioannides D
Clin Cosmet Investig Dermatol; 2016; 9():367-372. PubMed ID: 27799806
[TBL] [Abstract][Full Text] [Related]
31. The Curious Incidence of Mucinous Adenocarcinoma Masquerading as Perianal Hidradenitis Suppurativa.
Nasir H; Mohammad Azmi N; Dualim DM; Azman ZA; Abdul Rahman NA
Cureus; 2024 Apr; 16(4):e57585. PubMed ID: 38707052
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of hidradenitis suppurativa in patients with perianal fistula.
Ardon CB; Molenaar C; van Straalen KR; Scholtes VC; Prens EP; van der Zee HH
Int J Colorectal Dis; 2019 Jul; 34(7):1337-1339. PubMed ID: 31093736
[TBL] [Abstract][Full Text] [Related]
33. Intermammary Hidradenitis Suppurativa: A Case Report.
Dharmadji HP; Arianto TR; Sugiri U; Sutedja EK; Achdiat PA; Tsaqilah L; Gunawan H
Int Med Case Rep J; 2022; 15():163-167. PubMed ID: 35431584
[TBL] [Abstract][Full Text] [Related]
34. Atypical Clinical Presentation of Hidradenitis Suppurativa in a Patient with Severe Mannose-Binding Lectin Deficiency.
Bhargava S; Becker N; Kroumpouzos G
Case Rep Dermatol; 2020; 12(2):83-91. PubMed ID: 32508615
[TBL] [Abstract][Full Text] [Related]
35. Hidradenitis Suppurativa: An Interdisciplinary Problem in Dermatology, Gynecology, and Surgery-Pathogenesis, Comorbidities, and Current Treatments.
Nowak-Liduk A; Kitala D; Ochała-Gierek G; Łabuś W; Bergler-Czop B; Pietrauszka K; Niemiec P; Szyluk K; Gierek M
Life (Basel); 2023 Sep; 13(9):. PubMed ID: 37763299
[TBL] [Abstract][Full Text] [Related]
36. Long-Term Outcome of Adalimumab in a Young Girl with Hidradenitis Suppurativa.
Oranges T; Chiricozzi A; Iannone M; Romanelli M; Dini V
Skin Appendage Disord; 2018 Nov; 5(1):38-41. PubMed ID: 30643779
[TBL] [Abstract][Full Text] [Related]
37. Cervicofacial hidradenitis suppurativa: A case report and literature review.
Francois K; Moon HS; Panchal N
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Feb; 135(2):e25-e31. PubMed ID: 36241598
[TBL] [Abstract][Full Text] [Related]
38. Adalimumab Treatment in Women With Moderate-to-Severe Hidradenitis Suppurativa from the Placebo-Controlled Portion of a Phase 2, Randomized, Double-Blind Study.
Gottlieb A; Menter A; Armstrong A; Ocampo C; Gu Y; Teixeira HD
J Drugs Dermatol; 2016 Oct; 15(10):1192-1196. PubMed ID: 27741335
[TBL] [Abstract][Full Text] [Related]
39. Hidradenitis suppurativa: a review of current treatment options.
Lewandowski M; Świerczewska Z; Barańska-Rybak W
Int J Dermatol; 2022 Sep; 61(9):1152-1164. PubMed ID: 35128643
[TBL] [Abstract][Full Text] [Related]
40. Phytotherapeuthics Affecting the IL-1/IL-17/G-CSF Axis: A Complementary Treatment Option for Hidradenitis Suppurativa?
Witte K; Sabat R; Witte-Händel E; Ghoreschi K; Wolk K
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
